Cargando…

Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry

Background: Dl-3-n-Butylphthalide (NBP) has the potential to improve clinical outcomes in acute ischemic stroke patients by improving collateral circulation. We aimed to evaluate the efficacy and safety of NBP in patients with non-disabling minor ischemic stroke and transient ischemic attack (TIA)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Zefeng, Zhao, Yin, Yang, Wanyong, He, Shenwen, Ding, Yan, Xu, Anding
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492907/ https://www.ncbi.nlm.nih.gov/pubmed/34630292 http://dx.doi.org/10.3389/fneur.2021.720664

Ejemplares similares

Corrigendum: Efficacy and Safety of Adherence to dl-3-n-Butylphthalide Treatment in Patients With Non-disabling Minor Stroke and TIA—Analysis From a Nationwide, Multicenter Registry
por: Tan, Zefeng, et al.
Publicado: (2021)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Early Identification of High-Risk TIA or Minor Stroke Using Artificial Neural Network
por: Chan, Ka Lung, et al.
Publicado: (2019)

Clinical and imaging services for TIA and minor stroke: results of two surveys of practice across the UK
por: Brazzelli, Miriam, et al.
Publicado: (2013)

Microbleeds as a predictor of intracerebral haemorrhage and ischaemic stroke after a TIA or minor ischaemic stroke: a cohort study
por: Kwa, Vincent I H, et al.
Publicado: (2013)

Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance
por: Osei, Elizabeth, et al.
Publicado: (2021)

Predictors of quality of life 1 year after minor stroke or TIA: a prospective single-centre cohort study
por: Lam, Ka-Hoo, et al.
Publicado: (2019)

DL-3-n-butylphthalide Increases Collateriogenesis and Functional Recovery after Focal Ischemic Stroke in Mice
por: Wei, Zheng Zachory, et al.
Publicado: (2021)

Hyperhomocysteinemia is Associated with Aortic Atheroma Progression in Stroke/TIA Patients
por: Sen, Souvik, et al.
Publicado: (2010)

Impact of type of oral anticoagulants in patients with cerebral microbleeds after atrial fibrillation-related ischemic stroke or TIA: Results of the NOACISP-LONGTERM registry
por: Wagner, Benjamin, et al.
Publicado: (2022)

Dl-3-n-butylphthalide inhibits neuroinflammation by stimulating foxp3 and Ki-67 in an ischemic stroke model
por: Liu, Xi, et al.
Publicado: (2021)

Vascular protection and regenerative effects of intranasal DL-3-N-butylphthalide treatment after ischaemic stroke in mice
por: Qu, Mengyao, et al.
Publicado: (2020)

Protective effects of dl-3n-butylphthalide against diffuse brain injury
por: Zhao, Yaning, et al.
Publicado: (2013)

Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
por: Chen, Yajing, et al.
Publicado: (2019)

Large Vessel Occlusion in Patients With Minor Ischemic Stroke in a Population-Based Study. The Dijon Stroke Registry
por: Duloquin, Gauthier, et al.
Publicado: (2022)

Association between kinking of the cervical carotid or vertebral artery and ischemic stroke/TIA
por: Wang, Junjie, et al.
Publicado: (2022)

DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials
por: Wang, Huan, et al.
Publicado: (2022)

External Validation of the Diagnosis of TIA (DOT) Score for Identification of TIA in a Chinese Population
por: Yuan, Junliang, et al.
Publicado: (2019)

Dl-3-n-butylphthalide regulates cholinergic dysfunction in chronic cerebral hypoperfusion rats
por: Sun, Yanan, et al.
Publicado: (2020)

Dl-3-n-butylphthalide Reduces Neurovascular Inflammation and Ischemic Brain Injury in Mice
por: Yang, Chun-Sheng, et al.
Publicado: (2019)

Corrigendum: Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation
por: Chen, Yajing, et al.
Publicado: (2021)

Protocol of End-PSCI trial: a multicenter, randomized controlled trial to evaluate the effects of DL-3-n-butylphthalide on delayed-onset post stroke cognitive impairment
por: Liu, Ziyu, et al.
Publicado: (2022)

Butylphthalide Combined With Conventional Treatment Attenuates MMP-9 Levels and Increases VEGF Levels in Patients With Stroke: A Prospective Cohort Study
por: Xiong, Yingqiong, et al.
Publicado: (2021)

Factors associated with functional disability in patients with acute stroke excluded from alteplase administration due to minor non-disabling neurological deficits
por: Kim, Yong Jin, et al.
Publicado: (2022)

A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis
por: Liu, Mingsheng, et al.
Publicado: (2023)

Dl-3-n-Butylphthalide Ameliorates Diabetic Nephropathy by Ameliorating Excessive Fibrosis and Podocyte Apoptosis
por: Xu, Jingyu, et al.
Publicado: (2021)

Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry
por: Gutiérrez-Zúñiga, Raquel, et al.
Publicado: (2020)

Spatiotemporal analysis of regional TIA trends
por: Kawai, Andrew, et al.
Publicado: (2022)

Potential missed opportunities to prevent ischaemic stroke: prospective multicentre cohort study of atrial fibrillation-associated ischaemic stroke and TIA
por: Wilson, Duncan, et al.
Publicado: (2019)

Network Mapping of Time to Antithrombotic Therapy Among Patients With Ischemic Stroke and Transient Ischemic Attack (TIA)
por: Phan, Thanh G., et al.
Publicado: (2021)

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
por: Ma, Yan, et al.
Publicado: (2018)

Age-Dependent Differences in the Rate and Symptoms of TIA Mimics in Patients Presenting With a Suspected TIA to a Neurological Emergency Room
por: Ippen, Franziska Maria, et al.
Publicado: (2021)

Effects of Dl-3-n-butylphthalide on Cerebral Ischemia Infarction in Rat Model by Mass Spectrometry Imaging
por: Liu, Run-Zhe, et al.
Publicado: (2017)

Dl-3-n-Butylphthalide promotes neovascularization and neurological recovery in a rat model of intracerebral hemorrhage
por: Tu, Ewen, et al.
Publicado: (2020)

Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II
por: Yang, Ming, et al.
Publicado: (2019)

Anticoagulation After Ischemic Stroke or Transient Ischemic Attack (TIA) in the Time of Direct Oral Anticoagulation (DOAC) and Thrombectomy
por: Martin Diaz, Claudia, et al.
Publicado: (2021)

Microalbuminuria could improve risk stratification in patients with TIA and minor stroke
por: Elyas, Salim, et al.
Publicado: (2016)

MRA-detected intracranial atherosclerotic disease in patients with TIA and minor stroke
por: Dempsey, Philip J., et al.
Publicado: (2022)

Short- and long-term mortality of subarachnoid hemorrhage according to hospital volume and severity using a nationwide multicenter registry study
por: Park, Sang-Won, et al.
Publicado: (2022)

Prediction for the Total MRI Burden of Cerebral Small Vessel Disease With Retinal Microvascular Abnormalities in Ischemic Stroke/TIA Patients
por: Shu, Liming, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vh88phjctc7qp6lssa52lrugan